Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
1(17%)
Results Posted
0%(0 trials)
Terminated
1(17%)

Phase Distribution

Ph phase_3
1
17%
Ph phase_4
5
83%

Phase Distribution

0

Early Stage

0

Mid Stage

6

Late Stage

Phase Distribution6 total trials
Phase 3Large-scale testing
1(16.7%)
Phase 4Post-market surveillance
5(83.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(3)
Completed(1)
Terminated(1)
Other(1)

Detailed Status

Not yet recruiting2
Completed1
Recruiting1
Terminated1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
50.0%
Most Advanced
Phase 4

Trials by Phase

Phase 31 (16.7%)
Phase 45 (83.3%)

Trials by Status

completed117%
recruiting117%
terminated117%
unknown117%
not_yet_recruiting233%

Recent Activity

Clinical Trials (6)

Drug Details

Intervention Type
DRUG
Total Trials
6